Cochrane Abstracts
Cannabinoid type 1 receptor antagonists for smoking cessation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cannabinoid Type 1 Receptor Antagonists for Smoking Cessation." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439630/all/Cannabinoid_type_1_receptor_antagonists_for_smoking_cessation.
Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439630/all/Cannabinoid_type_1_receptor_antagonists_for_smoking_cessation. Accessed March 27, 2025.
Cannabinoid type 1 receptor antagonists for smoking cessation. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439630/all/Cannabinoid_type_1_receptor_antagonists_for_smoking_cessation
Cannabinoid Type 1 Receptor Antagonists for Smoking Cessation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439630/all/Cannabinoid_type_1_receptor_antagonists_for_smoking_cessation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cannabinoid type 1 receptor antagonists for smoking cessation
ID - 439630
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439630/all/Cannabinoid_type_1_receptor_antagonists_for_smoking_cessation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
